2022
DOI: 10.1371/journal.pcbi.1010038
|View full text |Cite
|
Sign up to set email alerts
|

Predicting the functional impact of KCNQ1 variants with artificial neural networks

Abstract: Recent advances in experimental and computational protein structure determination have provided access to high-quality structures for most human proteins and mutants thereof. However, linking changes in structure in protein mutants to functional impact remains an active area of method development. If successful, such methods can ultimately assist physicians in taking appropriate treatment decisions. This work presents three artificial neural network (ANN)-based predictive models that classify four key function… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 48 publications
0
6
0
Order By: Relevance
“…For example, application of computational prediction methods (including PolyPhen2, and PROVEAN) to LQTS genes has been shown to be moderately successful for predicting pathogenic KCNQ1 (LQTS type 1) and hERG (KCNH2; LQTS type 2) variants but less so for cardiac Na + channel variants (SCN5A; LQTS type 3) ( Leong et al, 2015 ) where LQTS (type 3) pathogenicity is predominantly associated with a gain of function (GOF) phenotype, with gating deficiencies (perturbed inactivation) in otherwise folding-competent pathogenic SCN5A variants ( Giudicessi et al, 2018 ). New channel-specific computational tools [e.g., ( Heyne et al, 2020 ; Zhang et al, 2020 ; Phul et al, 2022 )] may improve variant phenotype predictability, although experimental phenotyping is still required to improve confidence for clinical decision making. While EC analysis may be informative in structural analysis of Na + channels it is not expected to be useful in itself for predicting SCN5A LQTS type 3 variant phenotypes.…”
Section: Resultsmentioning
confidence: 99%
“…For example, application of computational prediction methods (including PolyPhen2, and PROVEAN) to LQTS genes has been shown to be moderately successful for predicting pathogenic KCNQ1 (LQTS type 1) and hERG (KCNH2; LQTS type 2) variants but less so for cardiac Na + channel variants (SCN5A; LQTS type 3) ( Leong et al, 2015 ) where LQTS (type 3) pathogenicity is predominantly associated with a gain of function (GOF) phenotype, with gating deficiencies (perturbed inactivation) in otherwise folding-competent pathogenic SCN5A variants ( Giudicessi et al, 2018 ). New channel-specific computational tools [e.g., ( Heyne et al, 2020 ; Zhang et al, 2020 ; Phul et al, 2022 )] may improve variant phenotype predictability, although experimental phenotyping is still required to improve confidence for clinical decision making. While EC analysis may be informative in structural analysis of Na + channels it is not expected to be useful in itself for predicting SCN5A LQTS type 3 variant phenotypes.…”
Section: Resultsmentioning
confidence: 99%
“…We suggest further work on the dataset for missense variants of KCNQ2 by incorporating unseen variants from the gnomAD database or recently reported studies. Designing new features for variant characterization, such as the change in the number of hydrogen donor or acceptor sites, would improve classification metrics as proposed in [ 58 ]. Advances in protein structure prediction (e.g., AlphaFold2) as well as cryo-EM technologies could lead to the design of more complex 3D features that could lead to a breakthrough in the prediction of variant pathogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…This work pursued two main objectives: (1) developing a ML model to improve accuracy for predicting the pathogenicity of KCNQ2 missense variants by combining biological-evolutive information, physico-chemical changes and structural features; and (2) creating a framework that can be extended to the prediction of the pathogenicity of variants occurring in other genes. Although there was currently no specific ML based software for KCNQ2 , similar approaches have been applied to KCNQ1 , another member of the KCNQ family [Phul et al ., 2022; Draelos et al ., 2022; Li et al ., 2017].…”
Section: Discussionmentioning
confidence: 99%
“…While tools like FATHMM, CONDEL, PolyPhen2, MutPred2, SIFT or PROVEAN were trained using information from genome-wide genetic variation data [Pejaver et al ., 2020; Shihab et al ., 2013; Choi et al ., 2012; González-Pérez & López-Bigas, 2011; Adzhubei et al ., 2010; Ng & Henikoff, 2001]; MLe-KCNQ2 was specifically trained with KCNQ2 missense variants. This reflects that development of genome-wide tools was based on heterogeneous datasets including a wide range of proteins with diverse functions and associated diseases [Phul et al ., 2022]. As a direct consequence, their prediction accuracy can vary between genes [Richards et al ., 2015].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation